Patients in our cohort had a mortality rate of 4% during the follow-up and deaths occurred at relatively young age, similar to patients in our SLE cohort.41Of note, the presence of any aPL among our SLE patients was predictive for CV-related mortality. This evidence concerns the gene FASLG and systemic lupus erythematosus.